Predictions
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.71
14.05.24
14.05.24
€3.00
14.05.25
14.05.25
25.85%
15.05.24
15.05.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Novavax Inc.
Start price
Target price
Perf. (%)
€12.15
13.05.24
13.05.24
-
13.05.25
13.05.25
16.83%
25.05.24
25.05.24
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Insmed Inc.
Start price
Target price
Perf. (%)
€23.60
13.05.24
13.05.24
€15.00
13.05.25
13.05.25
0.00%
14.05.24
14.05.24
Could be very worthwhile Investment >20% year
Heartland Express Inc.
Start price
Target price
Perf. (%)
€10.80
13.05.24
13.05.24
€20.00
13.05.25
13.05.25
-2.78%
27.05.24
27.05.24
Could be very worthwhile Investment >20% year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.36
13.05.24
13.05.24
€2.00
13.05.25
13.05.25
14.74%
14.05.24
14.05.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Papa John's International Inc.
Start price
Target price
Perf. (%)
€48.80
13.05.24
13.05.24
€73.00
13.05.25
13.05.25
-10.25%
27.05.24
27.05.24
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.43
12.05.24
12.05.24
-
12.05.25
12.05.25
-11.73%
24.05.24
24.05.24
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
12.05.24
12.05.24
-
12.05.25
12.05.25
-21.69%
24.05.24
24.05.24
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€1.83
11.05.24
11.05.24
€1.00
11.05.25
11.05.25
-3.66%
19.05.24
19.05.24
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.12
11.05.24
11.05.24
€1.00
11.05.25
11.05.25
-8.33%
19.05.24
19.05.24
Biolife Solutions Inc
Start price
Target price
Perf. (%)
€18.50
11.05.24
11.05.24
€32.00
11.05.25
11.05.25
8.11%
19.05.24
19.05.24
Novavax Inc.
Start price
Target price
Perf. (%)
€8.70
11.05.24
11.05.24
€82.00
11.05.25
11.05.25
39.26%
19.05.24
19.05.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
MacroGenics Inc.
Start price
Target price
Perf. (%)
€4.37
10.05.24
10.05.24
-
10.05.25
10.05.25
-27.99%
12.05.24
12.05.24
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.96
10.05.24
10.05.24
-
10.05.25
10.05.25
4.80%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year